| |
|
|
|
Forward Pharma Ads  
|
|
6.74 0.24 (0.04%) |
08-07 16:00 |
|
Open: |
6.42 |
Pre close: |
6.5 |
Target:
|
8.44 
|
|
High: |
6.75 |
Low: |
6.3 |
Resistance:
|
7.23
8.44
|
|
Volume: |
68,762 |
Market Cap: |
46M |
Support:
|
6.42
5.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.61
|
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
6.43 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
6.28 |
Stochastic Oscillator |
%K(14,3):
|
45.40 |
|
MA(250): |
6.43 |
%D(3): |
45.68 |
|
Average Volume(K) |
3-Month: |
11613
|
52-Week |
High:
|
12.72 |
|
10-Days: |
6405 |
Low: |
4.61 |
|
RSI |
RSI(14):
|
57.42 |
Change(%): |
4.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.620 |
Return on Equity (ttm) |
-5.3 |
Shares Out. (M) |
6.89 |
|
EPS Est. Current Year |
2.490 |
Return on Assets (ttm) |
-4.1 |
Shares Float (M) |
0.50 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.830 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.49 |
|
Forward EPS |
-0.090 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5 |
|
Book Value (p.s.) |
11.420 |
EBITDA (p.s.) |
-0.766 |
P/E |
-10.87 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.59 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-2.23 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.45 |
P/CF |
-20.82 |
|
|
|
|
|
|
